Webvent

Center for Pharmaceutical Research, AMR

Tomorrow's Medicine Today!

Center for Pharmaceutical Research, AMR

The Center for Pharmaceutical Research (CPR) is a privately owned clinical research center specializing in Phase I, II, III, and IV clinical trials for the pharmaceutical, nutraceutical, and medical device industries. 

CPR has two primary missions, each equally important: to provide ethical, safe, cutting-edge medical care for our volunteers and high-quality, clean data to our sponsors with strict adherence to GCP guidelines. 

John E. Ervin, MD, FACP, FACR founded The Center for Pharmaceutical Research in 1986, and serves as the CEO, Medical Director, and Principal Investigator.

The Center for Pharmaceutical Research was audited by the FDA in 1995, 2010, 2013, and 2015 with no findings and no 483’s issued.  Since its inception, CPR has conducted more than 700 trials in most areas of multispecialty research.

Products 

  • Phase I, II, III, and IV clinical trials in all areas of multispecialty research.

    Acid Reflux
    Allergy
    Asthma
    Bio-Terrorism Vaccines
    BPH
    Cancer Vaccines
    Constipation
    Dermatology
    Diabetes
    DPN
    Erectile Dysfunction
    Female Sexual Dysfunction
    Fibromyalgia
    High Cholesterol/Lipids
    Hypertension
    Insomnia
    Men’s Health
    Migraine
    Nephrology

    Obesity
    Oral Contraceptive
    Orthopedics
    Osteoarthritis
    Pediatrics
    Pediatric Vaccines
    Phase I Vaccines
    PHN
    Premature Ejaculation
    Psoriasis
    Respiratory
    Rheumatoid Arthritis
    Rosacea
    Seasonal Allergies
    Sleep Disorders
    Smoking Cessation
    Urology
    Vaccines
    Women’s Health


    More Information » www.cprkc.com

Web Site: cprkc.com 

Information

  • Center for Pharmaceutical Research, AMR
    Missy MacPhail
    1010 Carondelet Drive Suite 426
    Kansas City, Missouri 64114
    United States
    Map It »
    cprkc.com
  • Products1
  • Last UpdatedOctober 30, 2019 3:01pm EDT

Connect

Contact

  • Jason Huntington

    Director of Business Development
    Center for Pharmaceutical Research
    Kansas City, Missouri